CU Anschutz researchers uncovered a link between a type of mucosal immune cell and gut inflammation, finding that the cells ...

James Cook University (JCU) researchers have discovered that the same chemical compounds produced by mountain-top plants to ...

Ulcerative colitis is a chronic, immune-mediated disorder of the colon, which is characterised by a relapsing–remitting course. Owing to the growing understanding of the immunopathogenesis of this ...

A coroner has criticised the disjointed care a 74-year-old woman received before she died at a South London hospital.

The treatment of relapsed/refractory multiple myeloma dramatically changed in recent years with the emergence of therapies ...

This November, in honour of Crohn's and Colitis Awareness Month, Crohn's and Colitis Canada is spotlighting the courage and resilience of children and youth living with inflammatory bowel disease (IBD ...

A naturally occurring metabolic compound, pyruvate, has been identified as a potent suppressor of inflammation in ulcerative ...

Patients with immune checkpoint inhibitor colitis initially treated with high-dose glucocorticoids had a higher risk for ...

Surgery may be an option to manage ulcerative colitis when treatment with medication and lifestyle changes isn’t effective, ...

AUSTIN, Texas, Oct. 26, 2025 /PRNewswire/ -- Cristcot, a clinical-stage pharmaceutical company advancing targeted therapies for gastrointestinal diseases, today announced that the Company is ...

Unequal global access to inflammatory bowel disease (IBD) therapies creates profound health inequities. The increasing prevalence of IBD in Western countries, driven by high incidence rates and low ...

AnaptysBio ends its ulcerative colitis trial after rosnilimab misses key goals, focusing resources on rheumatoid arthritis ...